Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 3 1

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 33 Neoplasms 16 Prostatic Neoplasms 15 Lung Neoplasms 11 Carcinoma, Hepatocellular 11 Multiple Myeloma 9 Colorectal Neoplasms 9 Carcinoma, Non-Small-Cell Lung 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Papillomavirus Infections 6 Pain, Postoperative 6 Neoplasm Metastasis 6 Liver Neoplasms 6 Leukemia, Myeloid, Acute 6 Stomach Neoplasms 5 Recurrence 5 Lymphoma, Non-Hodgkin 4 Kidney Neoplasms 4 Heart Failure 4 Glioma 4 Febrile Neutropenia 4 Carcinoma, Renal Cell 4 Brain Neoplasms 4 Warts 3 Vomiting 3 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Skin Neoplasms 3 Rectal Neoplasms 3 Pituitary Neoplasms 3

Interventions

Dopamine Agonists 1 Cabergoline 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Recruiting × Prolactinoma × Clear all

NCT07045935 2025-09-23

ProBOLIC

University Hospital, Basel, Switzerland

Phase 4 Recruiting

Prolactin Deficiency, Isolated, Hyperprolactinemia, Prolactinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡